Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTI-015 (carmustine) before surgery for recurrent glioma or brain metastases
NCT00009854Phase 2Unknown
- Start
- Jun 2000
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carmustine in ethanol in malignant glioma and brain metastasis (BM). Primary endpoints: Extent and pattern of distribution of DNA adducts, Qualitative and quantitative toxicity at 12 weeks and 1 more. Status: unknown.
02
Drugs
carmustine in ethanol
03
Conditions
malignant gliomabrain metastasis (BM)
Beyond the preview
Go deeper on NCT00009854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009854.